Insulet (PODD) Capital Expenditures (2010 - 2026)

Insulet's Capital Expenditures history runs 17 years deep, the most recent figure standing at $24.3 million for Q1 2026.

• Quarterly Capital Expenditures rose 97.56% year-over-year to $24.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $203.6 million (up 1313.89% YoY) and the FY2025 annual result came in at $191.6 million, up 2005.49% from the prior year.
• Capital Expenditures was $24.3 million for Q1 2026 at Insulet, down from $178.1 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $178.1 million in Q4 2025 and bottomed at -$62.2 million in Q4 2024.
• A 5-year average of $18.4 million and a median of $7.8 million in 2022 frame the typical range for Capital Expenditures.
• Peak annual rise in Capital Expenditures reached 7950.0% in 2023, while the deepest fall reached 814.29% in 2023.
• Insulet's Capital Expenditures stood at $2.5 million in 2022, then jumped by 2676.0% to $69.4 million in 2023, then slumped by 189.63% to -$62.2 million in 2024, then soared by 386.33% to $178.1 million in 2025, then plunged by 86.36% to $24.3 million in 2026.
• Business Quant data shows PODD's Capital Expenditures at $24.3 million in Q1 2026, $178.1 million in Q4 2025, and $5.5 million in Q3 2025.